NCT05637580View on ClinicalTrials.gov

Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

May 20, 2019

Primary Completion Date

July 1, 2022

Study Completion Date

July 1, 2022

Conditions
Non Small Cell Lung CancerImmunotherapyChemotherapyTumour, Residual
Interventions
DRUG

Timing of drug administration

The effect of drug administration timing on tumor and lymph node responses was observed.

Trial Locations (1)

510080

Guangdong Provincial People's Hospital, Guangzhou

All Listed Sponsors
lead

Guangdong Provincial People's Hospital

OTHER

NCT05637580 - Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC | Biotech Hunter | Biotech Hunter